"Urologie si Medicina de familie"

During the past decade, Dinu Uromedica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dinu Uromedica" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dinu Uromedica" are "Prostate Cancer" (3 trials), "Clear Cell Renal Carcinoma" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Dinu Uromedica" in a lesser frequency.

Most popular intervention types in "Dinu Uromedica" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (3 trials), "Goserelin acetate" (2 trials), "ABR-217620/naptumomab estafenatox" (1 trials), "IFN-alpha" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dinu Uromedica" are 3 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Dinu Uromedica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dinu Uromedica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dinu Uromedica, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".